Delivering New Epidurals
Fagron Sterile Services US (FSS) is pleased to announce the expansion of our Labor & Delivery portfolio to include fentaNYL BUPivacaine IV bags in multiple strengths, produced through cGMP compliant operations. These new ready-to-administer presentations are preservative free and support patient safety with:
• Tamper evident caps
• Labeling that features ASTM color standards, ISMP TALLman lettering, and color enhanced warning statements
• Label design differentiation between strengths to further mitigate risk for medication errors
Many practitioners rely on effective pain management solutions in the labor and delivery suite to support a positive birthing experience during a transformative and special time for their patients.
"Epidurals play a critical role in labor and delivery, so this launch marks another milestone in our commitment to provide customers with high-quality, ready-to-administer, intravenous solutions across the continuum of care. We look forward to continued customer collaborations that support their patientcare needs," said Ray Dixon, SVP of Commercial Operations for FSS.
FSS stands as the only vertically integrated 503B outsourcing partner for patient-centric healthcare establishments in the US. Fagron’s group networks of companies serves more than 30 countries. This unique perspective allows FSS to support the healthcare supply chain by enhancing reliability while advancing patient safety. More importantly, patients can get the critical medications they need, when they need them. Fagron, is a pioneer in pharmaceutical compounding with over three decades of expertise, leading the way on a global scale.
Learn more and request a free consultation today!
About Fagron Sterile Services US (FSS)
FSS is a globally integrated 503B outsourcing partner to patient-focused healthcare facilities, creating supply chain resiliency while advancing patient safety.
As an industry-leader in 503B Outsourcing, FSS supports patient-focused healthcare facilities across North America with a reliable supply of critical high-quality sterile medications produced through cGMP-compliant operations.
The FSS team includes operational and regulatory expertise in pharmaceutical manufacturing and repackaging while leveraging industry-leading automation, advanced environmental monitoring, and sophisticated in-house quality testing labs. Batches are validated to support proper Beyond-Use Dating(BUD) and are only released after successful sterility, particulate matter, and potency testing are complete.
A broad product portfolio includes ready-to-administer critical care, labor and delivery, pain management, ophthamlics (including Avastin®), and other specialty medications like the only sterile LET gel, a topical anesthetic. As a trusted 503B outsourcing partner, FSS holds Integrated Delivery Network (IDN) agreements within all major GPOs.
.jpg)
